Clinical Trial Update: Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating inhaled nitric oxide for renal protection during cardiopulmonary bypass in cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Coronary Artery Disease
• Heart Valve Diseases
• Kidney Injury

Snippet

Sponsor: Nikolay Kamenshchikov | Conditions: Coronary Artery Disease, Heart Valve Diseases | Phase 1, Phase 2 | Status: COMPLETED